摘要
绿原酸(CGA)显示了肝癌、乳腺癌和皮肤癌的治疗可能性。与CGA刺激的癌细胞表现出差异表达的转录因子和调节分子,但分子的分子靶标是未知的。对CGA生原体的元素与Curcumin叠加了0.90最大公共子结构分。分子模拟研究进一步表明,CGA与PKC与氨基酸残基结合位点广泛互动C1B域。它结合PKC是浓度依赖性解离常数KD,28.84±3.95μM. pkc-cga复杂稳定,失真最小的三维结构和维持氢键配体和受体之间的模拟期间。与CGA刺激的细胞会导致从细胞质到质膜12.1°C 0.56% PKC易位。它扰乱了细胞周期使癌细胞在G1期S期细胞减少。绿原酸具有杀灭癌细胞以剂量依赖的方式与75.88±4.54μμg/ml和52.5±4.72μg/mL对MDA-MB-231和MCF-7细胞的IC50分别为。它在肿瘤细胞中诱导细胞凋亡的AO /溴化乙锭染色和DNA梯状条带明显降解给。在癌细胞凋亡的线粒体途径中涉及的线粒体膜电位和释放进入细胞质减少,支持细胞。因此,目前的研究已经建立了PKC作为一个重要的信号分子所观察到的抗癌作用的CGA,并提供动力,设计更好的CGA类似物,提高抗癌潜力对恶性肿瘤。
关键词: 激动剂,肿瘤,细胞周期,姜黄素,细胞色素C,对接,线粒体,蛋白激酶C,PMA,易位。
Current Molecular Medicine
Title:Evidence of PKC Binding and Translocation to Explain the Anticancer Mechanism of Chlorogenic Acid in Breast Cancer Cells
Volume: 17 Issue: 1
关键词: 激动剂,肿瘤,细胞周期,姜黄素,细胞色素C,对接,线粒体,蛋白激酶C,PMA,易位。
摘要: Chlorogenic acid (CGA) exhibits potentials towards liver, breast and skin cancer. Cancer cells stimulated with CGA exhibits differential expression of transcriptional factors and regulatory molecules but the molecular target of the molecule is not known. Superposition of biophoric elements of CGA with Curcumin gives maximum common substructure score of 0.90. Molecular modeling studies further suggest that CGA fits into the C1b domain of PKC with extensive interaction with residues lining binding site. It binds PKC in a concentration dependent manner with dissociation constant KD, 28.84±3.95 μM. PKC-CGA complex is stable with minimal distortion to the 3-D structure and maintains the hydrogen bonding between ligand and receptor during simulation period. Cells stimulated with CGA causes 12.1 ± 0.56% PKC translocation from the cytosol to the plasma membrane. It disturbs the cell cycle and arrest the cancer cell at the G1 phase with a reduction in S-phase. Chlorogenic acid exhibits killing of cancer cells in a dose-dependent manner with an IC50 of 75.88 ± 4.54μg/ml and 52.5 ± 4.72μg/ml towards MDAMB-231 and MCF-7 cells respectively. It induces apoptosis in cancer cells as evident by AO/EtBr staining and degradation of genomic DNA to give a laddering pattern. Apoptosis in cancer cells involves mitochondrial pathway as supported by a reduction in mitochondrial potentials and release of cyt-C into the cytosol. Hence, the current study has established PKC as an important signaling molecule to the observed anti-cancer effects of CGA and provides the impetus to design better CGA analogs for improved anti-cancer potential against the malignant tumor.
Export Options
About this article
Cite this article as:
Evidence of PKC Binding and Translocation to Explain the Anticancer Mechanism of Chlorogenic Acid in Breast Cancer Cells, Current Molecular Medicine 2017; 17 (1) . https://dx.doi.org/10.2174/1566524017666170209160619
DOI https://dx.doi.org/10.2174/1566524017666170209160619 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Comparative Proteomics Analysis of SKBR3 and MCF7 Breast Cancer Cell Lines Using Two Dimensional Electrophoresis: Ready to Build Postgenomics Capacity for OMICS R&D in Developing Countries?
Current Pharmacogenomics and Personalized Medicine Notch Signaling: A Potential Therapeutic Target in Prostate Cancer
Current Cancer Drug Targets Thyroid Hormone-Induced Angiogenesis
Current Cardiology Reviews Immune Checkpoint Inhibitors in the Treatment of Cancer
Current Reviews in Clinical and Experimental Pharmacology Multiple Myeloma and the Immune Microenvironment
Current Cancer Drug Targets The Genus Glycosmis [Rutaceae]: A Comprehensive Review on its Phytochemical and Pharmacological Perspectives
The Natural Products Journal Molecular Mechanisms, Emerging Etiological Insights and Models to Test Potential Therapeutic Interventions in Alzheimers Disease
Current Alzheimer Research 4'-Thionucleosides as Potent and Selective A<sub>3</sub> Adenosine Receptor Ligands
Current Organic Chemistry Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Actinomycetes as a Paramount Source of Biologically Important Enzyme Inhibitors – “A Boon to Mankind”
Current Bioactive Compounds Brain Inflammation Following Intracerebral Hemorrhage
Current Neuropharmacology Stem Cell Therapy for Ischaemic Stroke: Translation from Preclinical Studies to Clinical Treatment
CNS & Neurological Disorders - Drug Targets AICD Nuclear Signaling and Its Possible Contribution to Alzheimers Disease
Current Alzheimer Research Effects of Edible Algae Polysaccharides on Allergic, Inflammatory, and Anti-Tumor Responses Through Toll-Like Receptor 4
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Proteomics Approaches to Understand Linkage Between Alzheimer’s Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Drugs and their Interactions
Current Drug Discovery Technologies Role of Netrin-1 Beyond the Brain: From Biomarker of Tissue Injury to Therapy for Inflammatory Diseases
Recent Patents on Biomarkers Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease
Current Cardiology Reviews Recent Progress in the Development of Selective TRPV1 Antagonists for Pain
Current Topics in Medicinal Chemistry Chemistry and Theranostic Applications of Radiolabeled Nanoparticles for Cardiovascular, Oncological, and Pulmonary Research
Current Topics in Medicinal Chemistry